Saskia Middeldorp: The Use of LMWH in Women With Pregnancy Complications
Saskia Middeldorp, Head and Professor of Internal Medicine at Radboudumc, shared a post on LinkedIn about a recent article by her, published in JTH, adding:
“In this commentary in Journal of Thrombosis and Haemostasis on the GROWTH trial, I summarize the lack of evidence, and the evidence of absence of effect, on the use of heparin LMWH for women with pregnancy complications. Thanks to all investigators who remain persistent on getting high-quality evidence that women deserve so much.
It has taken way too long to say goodbye to a promise of heparin that has never been firmly delivered but does harm patients with the burden of injections, costs, and false hope.”
Title: It is time to accept the painful truth: low-molecular-weight heparin does not improve outcomes in women with pregnancy complications
Authors: Saskia Middeldorp
Stay updated with Hemostatis Today.
-
Nov 3, 2026, 14:14Edward Barnard: New Study Identifies an Association Between O Negative Blood Group and Trauma Mortality
-
Nov 3, 2026, 14:05Paula Escarcena Fernández: Selective Genicular Artery Embolization for Complex Regional Pain Syndrome of the Knee
-
Nov 3, 2026, 13:55Heiko Tschauner: New NOM-253 Standard Sets Higher Requirements for Blood Services in Mexico
-
Nov 3, 2026, 13:51The Future of Coagulation Diagnostics From Laboratory Testing to Better Patient Care
-
Nov 3, 2026, 13:45Keiyona Coots: Patient Blood Management as a Cornerstone of Safer Healthcare
-
Nov 3, 2026, 13:37Godfred Oduro: Engaging Young Students in Thalassemia and Sickle Cell Disease Awareness
-
Nov 3, 2026, 13:31Nita Radhakrishnan: MRI T2 Reveals Hidden Cardiac and Hepatic Iron Overload in Thalassemia
-
Nov 3, 2026, 13:26Chancellor Donald: Bridging Hematology Innovation and Entrepreneurship to Advance Patient Care
-
Nov 3, 2026, 13:21Pete Stibbs: From Scientific Ideas to Clinical Impact